TickerFacts.

Aspira Women's Health Inc. (AWHL): Cash & Equivalents

Annual figures by period end, from SEC filings.

$1.75M
As of 2025-12-31
$477.0K
As of 2026-06-30
-49.1%
3-year compound annual growth
-36.2%
5-year compound annual growth
-21.0%
10-year compound annual growth
$37.18M2010-12-31: $22.91M2011-12-31: $22.48M2012-12-31: $8.01M2013-12-31: $29.50M2014-12-31: $22.96M2015-12-31: $18.64M2016-12-31: $5.24M2017-12-31: $5.54M2020-12-31: $16.63M2021-12-31: $37.18M2022-09-30: $20.55M2022-12-31: $13.31M2023-12-31: $2.60M2024-12-31: $1.77M2025-12-31: $1.75M$1.75M
2010-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$1.75M-0.8%2026-04-01, Balance as of period end
2024-12-31$1.77M-31.9%2026-04-01, Balance as of period end
2023-12-31$2.60M-80.5%2025-03-27, Balance as of period end
2022-12-31$13.31Mn/a2024-04-01, Balance as of period end
2022-09-30$20.55Mn/a2023-10-26, Balance as of period end
2021-12-31$37.18M+123.6%2023-10-26, Balance as of period end
2020-12-31$16.63Mn/a2022-03-31, Balance as of period end
No annual figure between 2017-12-31 and 2020-12-31.
2017-12-31$5.54M+5.7%2018-03-13, Balance as of period end
2016-12-31$5.24M-71.9%2018-03-13, Balance as of period end
2015-12-31$18.64M-18.8%2017-03-31, Balance as of period end
2014-12-31$22.96M-22.2%2016-03-30, Balance as of period end
2013-12-31$29.50M+268.5%2015-03-31, Balance as of period end
2012-12-31$8.01M-64.4%2014-03-31, Balance as of period end
2011-12-31$22.48M-1.9%2013-03-01, Balance as of period end
2010-12-31$22.91Mn/a2012-03-27, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Aspira Women's Health Inc. (AWHL)2025-12-31$1.75M-0.8%
Anbio Biotechnology (NNNN)2025-12-31$7.77M-34.0%
Biomerica Inc (BMRA)2026-05-31$1.31M-45.5%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$11.58M+34.1%
Immucell Corp (ICCC)2025-12-31$3.81M+1.3%
Alpha Teknova, Inc. (TKNO)2025-12-31$5.91M+59.4%
Volitionrx Ltd (VNRX)2025-12-31$1.12M-65.8%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$28.87M+1.8%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$155.46M-17.8%

Compare AWHL, NNNN, BMRA, IMDX side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗